Latest IQVIA News & Updates

See the latest news and media coverage for IQVIA. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
IQVIA

Life sciences data, analytics, and clinical research company

iqvia.com
Headquarters
Durham, United States
Company type
Public company
Number of employees
75,000+

Last updated

Latest news about IQVIA

In short: IQVIA reported strong Q1 2026 financial results, exceeding revenue and earnings estimates while raising its full-year EPS guidance.

Company announcements

  • IQVIA

    IQVIA board approves $2 billion share repurchase increase

    This raises the total authorization to $3.2 billion under the existing program. Repurchases depend on market conditions and have no expiration date.

  • IQVIA

    IQVIA reports Q1 2026 results

    Revenue reaches $4,151 million, up 8.4%. Adjusted EBITDA is $932 million. Raises full-year EPS guidance to $12.65-$12.95.

  • IQVIA

    IQVIA leads cost utility analysis

    The study in Belgium compares Control IQ technology with conventional insulin therapy for type 1 diabetes adults using IQVIA CORE Diabetes Model. It provides insights for access and reimbursement.

  • IQVIA

    IQVIA Institute releases Global R&D Trends 2026 report

    The annual report features interesting findings on global R&D trends.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about IQVIA

Track IQVIA and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

IQVIA competitors & trending companies

Browse news for competitors to IQVIA and other trending companies.